Lucid dreams, altered states, deep relaxation, euphoria, increased intuition, awareness, enhanced creativity, accelerated learning, psychic abilities, increased endorphin levels elimination of insomnia, and the symptoms of stress ...
long as there is breath in my body
The study of magnetism promises great discoveries in natural health and medicine. They include pain control and the arrest, management and development of immunity to numerous afflictions which plague mankind .
WHAT IS A MAGNET?
At one end of a magnet is a SOUTH pole with a vortex of electrons
rotating in a clockwise (dextrogyric) direction with a positive charge.
At the opposite end is a NORTH pole with a vortex of electrons rotating
in a counterclockwise (sinistrogyric) direction with a negative charge.
MAGNETIC ENERGY DOES NOT CURE ANYTHING - IT BALANCES THE BODY ENERGY, METABOLISM AND POLARITY THUS GIVING THE BIOLOGICAL SYSTEM A CHANCE TO HEAL ITSELF WHEN PROPER NUTRITION IS PROVIDED.
Magnetic energy has Reportedly been used successfully in over 150 conditions :
Magnetic Therapy for Pet and Pet Pals
Magnetic Therapy is often thought of just for people or just for horses, but it is actually the same for all animal forms. Illness and chronic states affect the human and animal body when tissue is stressed, becoming acidic and deoxygenated. Cellular regeneration is muted in an acidic/deoxygenated state causing arthritic tissue to develop instead of proper connective tissue, scar tissue instead of normal skin and muscle tissue, etc. Basically Magnetic Therapy is the use of static magnets to balance blood and tissue cells in an affected area, allowing the cells to become alkaline and oxygenated again. When cells are alkaline and oxygenated they respond properly, regenerate properly and will stop feeding the chronic state.
Animals are extremely sensitive to proper and improper energies. When a sick dog comes across a Proper magnetic field he will gravitate to it instinctively knowing it is helping him. Humans have lost that sensitivity and need to be convinced. The facts are available (1) but modern medicine has been slow to accept it, although some attention has been shown toward electromagnetic therapy. Surprisingly, the use of static or non-electric generated magnetics appears to work better and have less potential for side affects. There are a few different types of applications, all north, bipolar, and bipolar concentric, and all can be used successfully if used properly. It is suggested to have a good source for your magnetic purchases where the science is understood and instruction for proper application is available.
Scientists have discovered that cells in the body have a clockwise cellular
spin when sick, stressed or injured. If the body stays in this state
too long it becomes chronic, while cells in a healthy body spin in a
counter clockwise direction and are alkaline and oxygenated. Much talk
has been made in health circles about eating foods to create a greater
alkaline state in the body and for proper tissue function. With the proper magnetic
application we can create this counter -clockwise alkaline/oxygen
state instantly in a particular body area or the whole body if a large
enough field is used. Simply correct the cellular spin in tissue and
allow it to return to a normal process of correctly rebuilding itself.
(1) “Cancer - The Magnetic /Oxygen Answer” by William Philpot.
Magnetism is using Nature's Energy to help overcome the Magnetic Deficiency Syndrome while living in man made magnetic fields. The magnetic field therapy increases blood flow, nutrition and oxygen to the body's cells and tissues
Magnetic Therapy in its natural state is the dominant North Pole field of the Earth dominating over the life processes of the body. With a full magnetic field from the Earth the body goes through many actions to promote good growth, strengthen tissue and fight disease and damage from accidents or injury. However most of the Earth does not have a full magnetic field. Scientists tell us that as a normal process the Earth's poles reverse approximately every 5,000 years. This could explain the loss of a lot of dinosaur. As we move to this polarity switch, in about 2,000 years, the Earth's magnetic field is lessening. With a decreased field the body is not always able to make all the changes it should and it makes it unable to successfully protect itself. An interesting note is that there are only four places left on Earth with full magnetic fields. Two habitable and two are not. The not are the North Pole and the South Pole. The habitable are Sedona, Arizona and Lourdes, France - both known for healthy living and healing. They can be thought of as East and West Poles.
Magnetic Therapy works by affecting our blood. Normally the blood operates in a North Pole orientation, or under a North Pole effect. In this polarity the blood is oxygenated and its process of distributing nutrients and pulling wastes and toxins from injured tissue is made most efficient. When the body is ill or injured the polarity of the site is switched by the body to a South Pole orientation. This creates faster, excited movement meant to draw blood cells to the area for healing. The blood does not work well in a South Pole orientation. Its movement does not allow normal function and an acid state is developed, which micro-organisms, viruses and malignance thrive in. *The chart below shows the affect of North and South Pole applications on the body.* Once the blood has been drawn to the area, the body, with the help of the Earth's magnetic field is supposed to change the polarity of the blood back to a North Pole orientation so positive activity by the blood may take place.
The problem is that with a reduced magnetic field the body can not always make this necessary conversion and the injury/illness area is left in a South Pole orientation thwarting good cell growth with its acid effect and slowing the healing process. Without blood removing wastes and toxins from injury/illness sites they are left there to fester and become unwanted bursas or arthritic tissue or bad calcification. The increase in conditions like Arthritis, Rheumatoid Arthritis, Fibromyalgia, ADD, ADHD and a multitude of cancers and other Auto-Immune system diseases have increased with the decrease of the magnetic field. Other problems are slow healing in fracture sets and longer recovery periods of disability after accidents. Another sign of this is the great increase in repetitive motion injuries in every form of business and sport. The answer in many cases is Proper Polarity Magnetic Therapy.
By applying a structured North Pole magnetic field, using high strength North Pole pad, we can convert the polarity of the blood in the injury/illness area allowing the blood to work as it should, pulling wastes and toxins away to the kidneys and other cleansing organs, clearing a path for good cell growth aided by the nutrients the blood can now deliver. Simple and totally natural. Use a Natural field to act as a catalyst to normal blood functions. The body can now heal itself naturally. Of course if there are broken bones or vertebrae out of place the magnets will not do it alone, this is time for a good chiropractor. Magnetic Therapy is only a piece of the health pie allowing us to avoid in many cases unnatural medicines and sometimes making surgical procedures unnecessary. Magnetic Therapy works great on many conditions and studies are coming up with more uses every day. Like the positive effects of drinking North Pole magnetized water for those with conditions like the Arthritis's, Fibromyalgia, Gout and ADHD to name a few. People are having great success but that's not a reason to avoid health professionals. After all without good diagnosis what do we treat? Magnetic Therapy works as well on Horses, Dogs and Cats as it does for people.
Apply a natural North Pole magnetic field. Convert the polarity of the blood to the North Pole orientated working polarity. Let the body heal itself. What is more natural than that?
The Magnetic Effect
BioMagnetics by Jerry W. Decker
One of the most important series of experiments ever done and yet still
not widely known, were those carried out by Albert Roy Davis in conjunction
with Walter Rawls. These experiments are FUNDAMENTAL to an understanding
of magnetic forces and are to this day not being used widely because
many have never heard of them.
Also, North Pole energies have alkaline properties while South Pole
energy is acid. North pole energies tend to collect fluids while South
Pole energies dissipate fluids. North pole energy is referred to as negative
because it reduces or attracts, while South pole energy is referred to
as positive because it expands and dissipates.
A new field of energy medicine is emerging. Magnetic energy can be used as a non- nutritional source of energy to evoke specific biological responses. Life is a matter of balance between north and south pole magnetic polarities and not just one or the other of the poles. The metabolic responses of biological systems to specific magnetic energy polarity and Gauss strength are consistently dependable. The body is an electrical as well as a chemical unit. Magnetic fields produce small electrical currents under the skin - sufficiently powerful enough to cause biological effects such as pain reduction, regeneration of cells and nerves, etc. Magnets usually work better than they are predicted to - they are the safest and finest therapy you can buy - nothing is better in many cases. If you sense any discomfort while wearing any magnetic device - take it off and the discomfort will go away very quickly. You don't have to worry about creating another conditions from an overdose. BEFORE USING MAGNETIC ENERGY YOU SHOULD FIND OUT WHY AND WHERE THE PAIN IS COMING FROM BY CONSULTING YOUR HEALTH PROFESSIONAL. The beauty of the universe and the biological systems within it is its marvelous simplicity, unity of design and orderliness. Negative magnetic energy can cause increased melatonin production by stimulating the pineal gland at night. Melatonin has been established as having the values of a master control over hormones, sleep, immune function, anti oxidants, infections, respiration, mineral metabolism and all other metabolic energy systems. While our body is recovering its biological energy loss, as we sleep, melatonin and growth hormone are active participants in this recovery process
Generate North,,South,,or AC Pulsed Magnetic fields Easily.
"Everything in life is vibration"Albert Einstein
Addiction Science Research and Education Center, College of Pharmacy, University of Texas. “Dopamine - A Sample Neurotransmitter.” University of Texas. Academic, 2000. Available at http://www.utexas.edu/research/asrec/dopamine.html (November 2004).
---. “Neurotransmitters Send Chemical "Messages".” University of Texas. Academic, 2000. Available at http://www.utexas.edu/research/asrec/synapse.html (November 2004).
---. “Other Neurostransmitters: Serotonin, Norepinephrine, Acetylcholine, Glutamate and GABA (gamma-amino butyric acid).” University of Texas. Academic, 2000. Available at http://www.utexas.edu/research/asrec/synapse.html (November 2004).
Ahrens, B., B. Muller-Oerlinghausen, and M. Schou. “Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis.” Journal of Affective Disorders 33 (1995): 67-75.
Akiskal, H.S., J. Downs, P. Jordan, S. Watson, D. Daugherty, and D.B. Pruitt. “Affective disorders in referred children and younger siblings of manic-depressives.” Archives of General Psychiatry 42 (1985): 996-1003.
---, J.D. Maser, and P.J. Zeller. “Switching from unipolar to bipolar II: an 11-year prospective study of clinical and temperamental predictors in 559 patients.” Archives of General Psychiatry 52 (1995): 114-123.
Anderson, C.A., and C.L. Hammen. “Psychosocial outcomes of children of unipolar depressed, bipolar, medically ill, and normal women: a longitudinal study.” Journal of Consult. Clin. Psychol. 61 (1993): 448-454.
Anyanwu, E., G.F. Harding, A. Edson, and Department of Vision Sciences, Aston University, Birmingham, UK. “The involvement of serotonin (5-hydroxytryptamine) in photosensitive epilepsy.” Journal of Basic Clinical Physiology and Pharmacology 5.3-4 (1994): 179-206.
Appleton, R., M. Beirne, and B. Acomb. “Photosensitivity in juvenile myoclonic epilepsy.” Seizure 9.2 (March 2000): 108-111.
Axel, Richard. “Representations of Olfactory Information in the Brain.” Howard Hughes Medical Institute. Research Foundation, October 2004. Available at http://www.hhmi.org/research/investigators/axel.html (November 2004).
Bailey, C.H., and E.R. Kandel. “Structural changes accompanying memory storage.” Annual Review of Physiology 55 (1993): 397-426.
Bateson, P.P.G. “The characteristics and context of imprinting.” Biological Review 41 (1966): 177-220.
Beaulieu, C., and M. Colonnier. “Effect of the richness of the environment on the cat visual cortex.” Journal of Comparative Neurology 266 (1987): 478-494.
Becker, L.E., D.L. Armstrong, and F. Chan. “Dendritic atrophy in children with Down syndrome.” Annual of Neurology 20 (1986): 520-526.
Bennet, E., and M. Rosenzweig. “Behavioral and biochemical methods to study brain responses to environment and experience.” In Methods in Neurobiology. Vol. 2, 101-141. 1981.
Biederman, J., S.V. Faraone, K. Keenan, and M.T. Tsuang. “Evidence of familial association between attention deficit disorder and major affective disorders.” Archives of General Psychiatry 48 (1991): 633-642.
---, J. Wozniak, and K Kiely. “CBCL clinical scales discriminate prepubertal children with structured interview-derived diagnosis of mania from those with ADHD.” Journal of American Academic Childhood and Adolescent Psychiatry 34 (1995): 464-471.
Black, J.E., W.T. Greenough, B.J. Anderson, and K.R. Isaacs. “Environment and the aging brain.” Canadian Journal of Psychology 41 (1987): 111-130.
---, M. Polinski, and W.T. Greenough. “Progressive failure of cerebralangiogenesis supporting neural plasticity in aging rats.” Neurobiological Aging 10 (1989): 353-358.
Bobula, B., A. Zahorodna, K. Tokarski, and G. Hess. “Use of models for spontaneous paroxysmal activity in studies of adaptive changes in serotonin receptors.” Postepy higieny i medycyny doswiadczalnej 56.3 (2002): 377-383.
Borchardt, C.M., and G.A. Bernstein. “Comorbid disorders in hospitalized bipolar adolescents compared with unipolar depressed adolescents.” Childhood Psychiatry and Human Development 26 (1995): 11-18.
Botteron, K.N., and B. Geller. “Pharmacologic treatment of childhood and adolescent mania.” Psychiatric Clinics of North America 4 (1995): 283-304.
---, M.W. Vannier, B. Geller, R.D. Todd, and B.C. Lee. “Preliminary study of magnetic resonance imaging characteristics in 8- to 16-year-olds with mania.” Journal of American Academic Childhood and Adolescent Psychiatry 34 (1995): 742-749.
Bottjer, S.W., and A.P. Arnold. “Developmental plasticity in neural circuits for a learned behavior.” Annual Review of Neuroscience 20 (1997): 459-481.
Brent, D.A., J.A. Perper, and C.E. Goldstein. “Risk factors for adolescent suicide: a comparison of adolescent suicide victims with suicidal inpatients.” Archives of General Psychiatry 45 (1988): 581-588.
---, J.A. Perper, and G. Moritz. “Psychiatric risk factors for adolescent suicide: a case-control study.” Journal of Academic Childhood and Adolescent Psychiatry 32 (1993): 521-529.
---, J.P. Zelenak, O. Bukstein, and R.V. Brown. “Reliability and validity of the structured interview for personality disorders in adolescents.” Journal of Academic Childhood and Adolescent Psychiatry 29 (1990): 349-354.
Brickner, D.D. “Educational synthesizer.” In Hey, don't forget about me!, ed. A. Thomas. VA: Council for Exceptional Children, 1976.
Brooks, P.H., and A.A. Baumeister. “A plea for consideration of ecological validity in the experimental psychology of mental retardation: A guest editorial.” American Journal of Mental Deficiency 81 (1977): 407-416.
Browning, R.A., A.V. Wood, M.A. Merrill, J.W. Dailey, and P.C. Jobe. “Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors.” European Journal of Pharmacology 336.1 (October 1997): 1-6.
Bruell, S.J., and P.D. Coleman. “Dendritic growth in the aged human brain and failure of growth in senile dementia.” Science 206 (1979): 854-856.
--- and P.D. Coleman. “Regulation of dendritic extent in developing and aging brain.” In Synaptic Plasticity, ed. C.W. Cotman, 311-333. New York: Raven, 1985.
Brunet, and Lézine. Echelle de Development Psychomoteur de la Première Enfance, rev. ed. Paris: Les Editions du Centre de Psychologies Appliquées, 1998.
Brunjes, P.C., and L.L. Frazier. “Maturation and plasticity in the olfactory system of vertebrates.” Brain Research Review 11 (1986): 145.
Calvin, W.H. The Cerebral Code. Cambridge, MA: MIT Press, 1996.
Carlson, G.A., and J.H. Kashani. “Manic symptoms in a non-referred adolescent population.” Journal of Affective Disorders 15 (1988): 219-226.
Cattell, P. Infant Intelligence Scale. New York: Psychological Corp., 1940.
Chaouloff, F., and . Serotonin regulates stress. Bordeaux, France: INSERM U47 1, Institut Megendie, .
Childs, B., and C.R. Scriver. “Age at onset and causes of disease.” Perspectives in Biology and Medicine 29 (1986): 437-460.
Chugani, D.C., and Departments of Pediatrics and Radiology, Children's Hospital of Michigan, Detroit Medical Center, Wayne State University School of Medicine, Detroit, Michigan. “Serotonin in autism and pediatric epilepsies.” Mental Retardation and Developmental Disabilities Research and Development 10.2 (2004): 112-116.
Clinckers, R., I. Smolders, A. Meurs, G. Ebinger, and Y. Michotte. “Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors.” Journal of Neurochemistry 89.4 (May 2004): 834-843.
Compan, V., M. Zhou, R. Grailhe, R. A. Gazzara, R. Martin, and J. Gingrich. “Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice.” Journal of Neuroscience 24.2 (January 2004): 412-419.
Cooper, T.B., P.E. Bergner, and G.M. Simpson. “The 24-hour serum lithium level as a prognosticator of dosage requirements.” American Journal of Psychiatry 130 (1973): 601-603.
Coryell, W., J. Endicott, J.D. Maser, M.B. Keller, A.C. Leon, and H.S. Akiskal. “Long- term stability of polarity distinctions in the affective disorders.” American Journal of Psychiatry 152 (1995): 385-390.
---, M. Keller, J. Endicott, N. Andreasen, P. Clayton, and R. Hirschfeld. “Bipolar II illness: course and outcome over a five-year period.” Psychol. Med. 19 (1989): 129-141.
---, W. Scheftner, M.B. Keller, J. Endicott, J. Maser, and G.L. Klerman. “The enduring psychosocial consequences of mania and depression.” American Journal of Psychiatry 150 (1993): 720-727.
Crowell, M. D. “The role of serotonin in the pathophysiology of irritable bowel syndrome.” American Journal of Managed Care 7.Suppl 8 (July 2001): 252-260.
Davis, J. M., N. L. Alderson, and R. S. Welsh. “Serotonin and central nervous system fatigue: nutritional considerations.” American Journal of Clinical Nutrition 72.Suppl 2 (August 2000): 573-578.
Decina, P., C.J. Kestenbaum, and S. Farber. “Clinical and psychological assessment of children of bipolar probands.” American Journal of Psychiatry 140 (1983): 548-553.
Delgado, P.L., and F.A. Moreno. “Hallucinogens, serotonin and obsessive-compulsive disorder.” Journal of Psychoactive Drugs 30.4 (1998): 359-366.
Di Matteo, V., A. De Blasi, C. Di Giulio, and E. Esposito. “Role of 5-HT(2C) receptors in the control of central dopamine function.” Trends in Pharmacological Science 22.5 (May 2001): 229-232.
Dominquez, H.D., M.F. Lopez, and J.C. Molina. “Interactions between perinatal and neonatal associative learning defined by contiguous olfactory and tactile stimulation.” Neurobiological Learning Memory 71.3 (1999): 272-288.
DuBose, R.F., and M.B. Langley. The developmental activities screening inventory. Boston: Teaching Resources, 1977.
Dugovic, C. “Role of serotonin in sleep mechanisms.” Review of Neurology (Paris) 157.11 (November 2001): 16-19.
Fetner, H.H., and B. Geller. “Lithium and tricyclic antidepressants.” Psychiatric Clinics of North America 15 (1992): 223-224.
Fewell, R.R., and University of Miami School of Medicine. “Play assessment scale.” 1992.
---P.F. Vadasy. “Supports from religious organizations and personal beliefs.” In Families of handicapped children: Needs and supports across the life span, ed. R.R. Fewell, 297-316. Austin, TX: PRO-ED, 1986.
---D. Weatherford. “The measurement of family functioning.” In Evaluating early intervention programs for severely handicapped children and their families, ed. L. Bickman, 263-307. Austin, TX: PRO-ED, 1986.
Folio, M.R., and R.F. DuBose. “Peabody developmental motor scales (Monograph No. 25).” , George Peabody College, IMRID Behavioral Research Institute, 1974.
Fraiberg, S.M. The magic years. New York: Charles Scribner's Sons, 1959.
Gage, Fred H. “BRAIN, REPAIR YOURSELF. How do you fix a broken brain? The answers may literally lie within our heads. The same approaches might also boost the power of an already healthy brain.” Scientific American (September 2003).
Gesell, A., and C.S. Amatruda. Developmental diagnosis, 2nd ed. New York: Paul B. Hoeber, 1947.
Gilliam, F. G., J. Santos, V. Vahle, J. Carter, K. Brown, and H. Hecimovic. “Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction?” Epilepsia 45.Suppl 2 (2004): 28-33.
Gordon-Pomares, C. L’Eveil Sensoriel de Mon Enfant. Paris: Hachette, 1995.
---. Manuel Pratique du Jouet. Paris: Hachette, 1998.
---. Papa, Maman, L’Ecole et Moi. Paris: Hachette, 1997.
Gray, J. A., and B. L. Roth. “Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists.” Brain Research Bulletin 56.5 (15 November 2001): 441-451.
Grimaldi, B., A. Bonnin, M. P. Fillion, N. Prudhomme, and G. Fillion. “5-Hydroxytryptamine-moduline: a novel endogenous peptide involved in the control of anxiety.” Neuroscience 93.4 (1999): 1223-1225.
--- and G. Fillion. “5-HT-moduline controls serotonergic activity: implication in neuroimmune reciprocal regulation mechanisms.” Progress in Neurobiology 60.1 (January 2000): 1-12.
Haeussermann, E. Developmental potential of preschool children. New York: Grune & Stratton, 1958.
Harvey, J.A. “Serotonin & Memory/Review: Role of the Serotonin 5-HT2A Receptor in Learning.” , Dept of Pharmacology and Physiology, Laboratory of Behavioral Neurobiology, Drexel University College of Medicine, Philadelphia, .
Heisler, L. K., M. A. Cowley, T. Kishi, L. H. Tecott, W. Fan, and M. J. Loe. “Central serotonin and melanocortin pathways regulating energy homeostasis.” Annals of the New York Academy of Sciences 994 (June 2003): 169-174.
Holloway, Marguerite. “THE MUTABLE BRAIN. Score one for believers in the adage "Use it or lose it." Targeted mental and physical exercises seem to improve the brain in unexpected ways .” Scientific American (September 2003).
Holsboer, F. “Stress, hypercorticolism and corticosteroid receptors in depression: implications for therapy.” Journal of Affective Disorders 62 (2001): 77-91.
Horvitz, J.C. “Dopamine.” http://www.columbia.edu. Academic, 2000. Available at http://www.columbia.edu/~jh299/DA.html#1989 (November 2004).
---. “Mesolimbic and nigrostriatal dopamine responses to salient non-reward events.” Neuroscience 96.4 (March 2000): 651-656.
--- and Y.S. Eyny. “Dopamine D2 receptor blockade reduces response likelihood but does not affect latency to emit a learned sensory-motor response: Implications for parkinson's disease.” Behavioral Neuroscience 114.5 (2000): 934-939.
---, W.B. Richardson, and A. Ettenberg. “Dopamine receptor blockade and thirst produce differential effects on drinking behavior.” Pharmacology Biochemistry and Behavior 45 (1993): 725-728.
---, T. Sterwart, and B.L. Jacobs. “Burst activity of ventral tegmental dopamine neurons is elicited by sensory stimuli.” Brain Research 759 (1997): 251-258.
Horwitz, J.C., T. Sterwart, B.L. Jacobs, and . “Burst activity of ventral tegmental dopamine neurons is elicited by sensory stimuli.” Brain Research 759 (1997): 251-258.
Johnson, B.A., S. Ho, Z. Xu, J.S. Yihan, S. Yip, and E.E. Hingco. “Functional mapping of the rat olfactory bulb using diverse odorants reveals modular responses to functional groups and hydrocarbon structural features.” Journal of Comparative Neurology 449 (2002): 180-194.
--- and M. Leon. “Modular glomerular representations of odorants in the rat olfactory bulb and the effects of stimulus concentration.” Journal of Comparative Neurology 422 (2000): 496-509.
--- and M. Leon. “Odorant molecular length: One aspect of the olfactory code.” Journal of Comparative Neurology 426 (2000): 330-338.
---, C.C. Woo, E.E. Hingco, K.L. Pham, and M. Leon. “Multidimensional chemotopic responses to n-aliphatic acid odorants in the rat olfactory bulb.” Journal of Comparative Neurology 409 (1999): 529-548.
---, C.C. Woo, and M. Leon. “Spatial coding of odorant features in the glomerular layer of the rat olfactory bulb.” Journal of Comparative Neurology 393 (1998): 457-471.
Kolb, B., M. Forgie, R. Gibb, G. Gorny, and S. Rowntree. “Age, experience and the changing brain.” Neuroscience and Behavioral Review 22 (1998): 143-159.
---, R. Gibb, and G. Gorny. “Cortical plasticity and the development of behavior after frontal cortical injury.” Developmental Neuropsychology 18 (2000): 423-444.
---, R. Gibb, and G. Gorny. “Experience-dependent changes in dendritic arbor and spine density in neocortex vary with age and sex..” Neurobiolgy of Learning and Memory 79 (2003): 1-10.
--- and I.Q. Wishaw. “Brain Plasticity and Behavior.” Annual Review of Psychology 49 (1998): 43-64.
LaHoste, G.J., and . “Dopamine D4 receptor gene polymorphism is associated with attention-deficit hyperactivity disorder.” Molecular Psychiatry 1.2 (May 1996): 121-124.
Langdon, J., and H. Down. “OBSERVATIONS ON AN ETHNIC CLASSIFICATION OF IDIOTS.” Clinical lectures and reports by the medical and surgical staff of the London Hospital 3 (1866): 259-62.
Lawrence, T.M. “Precision teaching in perspective: An interview with O. R. Lindsley.” Teaching Exceptional Children 3.3 (1971): 114-119.
Leon, M., R. Coopersmith, F.B. Weihmuller, C.L. Kirstein, and J.F. Marshall. “Extracellular dopamine increases in the neonatal olfactory bulb during odor preference training.” Brain Research 564.1 (1991): 149-153.
Linster, C., B.A. Johnson, A. Morse, E. Yue, and M. Leon. “Spontaneous vs. reinforced olfactory discriminations.” Journal of Neuroscience 22 (2002): 6842-6845.
---, B.A. Johnson, A. Morse, E. Yue, Z. Xu, and Y. and M. Choi. “Perceptual correlates of neural representations evoked by odorant enantiomers.” Journal of Neuroscience 21 (2001): 9837-9843.
Liu, Diorio, Tannenbaum, Caldji, Francis, and Freedman. “Maternal Care, Hippocampal Glucocorticoid Receptors, and Typothalamic-Pituitary-Adrenal Responses to Stress.” Science 277 (1997): 1659-1662.
Mann, J., A. McBride, and R. Brown. “Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients.” Archives of General Psychiatry 49 (1992): 442-446.
Matsumoto, M., and M. Yoshioka. “Possible involvement of serotonin receptors in anxiety disorders.” Nippon Yakurigatu Zasshi 2000.115 (1): 39-44.
McEwen, B.S. “Protective and damaging effects of stress mediators.” New England Journal of Medicine 338.3 (1998): 171-179.
McLean, J.H., and A. Darby-King. “Receptor involvement in conditioned olfactory learning in the neonate rat pup.” Behavioral Neuroscience 110 (1996): 1426-1434.
---, S. Darby-King, R.M. Sullivan, and S.R. King. “Serotonergic influence on olfactory learning in the neonate rat.” Behavioral Neural Biology 60.2 (1993): 152-162.
Meneses, A. “Endogenous serotonin (5-hydroxytryptamine [5-HT]) modulates plasticity processes, including learning and memory.” , Department of Pharmacobiology, CINVESTAV-IPN, Mexico, .
--- and Departamento de Farmacologia y Toxicologia, CINVESTAV-IPN, Mexico D.F., Mexico. “Physiological, pathophysiological and therapeutic roles of 5-HT systems in learning and memory.” Review of Neuroscience 9.4 (1998): 275-289.
--- and Departamento de Farmacologia y Toxicologia, CINVESTAV-IPN, Mexico D.F., Mexico. “5-HT system and cognition.” Neuroscience and Biobehavioral Reviews. 23.8 (1999): 1111-1125.
Merlet, I., K. Ostrowsky, N. Costes, P. Ryvlin, J. Isnard, and F. Lavenne. “5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an PET study.” Brain 127.4 (April 2004): 900-913.
---, P. Ryvlin, N. Costes, D. Dufournel, J. Isnard, and K. Ostrowsky. “Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG.” Neuroimage 22.2 (June 2004): 886-896.
Mitchell, J.B., and A. Gratton. “Mesolimbic dopamine release elicited by activation of the accessory olfactory system: a high-speed chronoamperometric study.” Neuroscience Letter 140.1 (1992): 81-84.
Mombaerts, P., F. Wang, C. Dulac, R. Vassar, S.K. Chao, A. Nemes, and Department of Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, College of Physicians and Surgeons, Columbia University, New York. “The molecular biology of olfactory perception.” Cold Spring Harb Symp. Quant. Biol. 61 (1996): 135-145.
Murphy, C., and S. Jinich. “Olfactory dysfunction in Down syndrome.” Neurobiological Aging 17.4 (1996): 631-637.
Nadi, N.S., R. Head, M. Grillo, J. Hempstead, N. Grannot-Reisfeld, and F.L. Margolis. “Chemical deafferentation of the olfactory bulb: plasticity of the levels of?tyrosine hydroxylase, dopamine and norepinephrine..” Brain Research.213 (June 1981), 365-377.
Naughton, M., J.B. Mulrooney, and B.E. Leonard. “A review of the role of serotonin receptors in psychiatric disorders.” Human Psychopharmacology 15.6 (2000): 397-415.
Philpot, B.D., D. Men, R. McCarty, and P.C. Brunjes. “Activity-dependent regulation of dopamine content in the olfactory bulbs of naris-occluded rats.” Journal of Neuroscience 85.3 (1998): 969-977.
Pitts, S.M., and J.C. Horvitz. “Similar effects of D1/D2 receptor blockade on feeding and locomotor behavior.” Pharmacology Biochemistry and Behavior 65 (2000): 433-438.
Rangel, S., and M. Leon. “Early odor preference training increases olfactory bulb norepinephrine.” Journal of Developmental Brain Research 85.2 (1995): 187-191.
Robbins, N. “The teaching of a manual sign as a diagnostic tool with deaf-blind children.” In Fourth International Conference on Deaf-Blind Children. Waterton, MA: Perkins School for the Blind, 1971.
Rosenzweig, M. “Experience, memory and the brain.” Journal of American Psychology 39.4 (1984): 365-376.
---, E. Bennet, and J. Flood. “Pharmocological modulation of formation of long-term memory..” In Brain and Behavior. Vol. 17, 101-111. 1981.
Royet, J.P., F. Jourdan, H Ploye, and C Souchier. “Morphometric modifications associated with early sensory experience in the rat olfactory bulb: II. Stereological study of the population of olfactory glomeruli.” Journal of Comparative Neurology 289.4 (1989): 594-609.
Saito, H., M. Matsumoto, H. Togashi, and M. Yoshioka. “Functional interaction between serotonin and other neuronal systems: focus on in vivo microdialysis studies.” Japanese Journal of Pharmacology 70.3 (March 1996): 203-205.
Sapolsky, Robert. “TAMING STRESS. An emerging understanding of the brain's stress pathways points toward treatments for anxiety and depression beyond Valium and Prozac .” Scientific American (September 2003).
Schaal, B., H. Montagner, E. Hertling, D. Bolzoni, A. Moyse, and R. Quichon. “Les stimulations olfactives dans les relations entre l’enfant et la mère.” Nutrition and Development 20.3B (1980): 843-858.
Sevcik, J., P. Petrovicky, V. Ruzicka, J. Slansky, and K. Masek. “Structures and pathways of the central nervous system are potentially involved in the serotonergic modulation of gastrointestinal activity.” Methods and findings in experimental and clinical pharmacology. 24.10 (2002): 669-673.
Silberstein, S. D. “Serotonin (5-HT) and migraine.” Headache 34.7 (1994): 408-417.
Southwick, S. M., S. Paige, C. A. Morgan, J. D. Bremner, J. H. Krystal, and D. S. Charney. “Neurotransmitter alterations in PTSD: catecholamines and serotonin.” Seminars in clinical neuropsychiatry 4.4 (October 1999): 242-248.
Steiger, H., M. Isra‘l, N. Koerner, N. Kin, J. Paris, and S.N. Young. “Bulimia nervosa (BN) is reported to co-occur with childhood abuse and alterations in central serotonin (5-hydroxytryptamine [5-HT]) and cortisol mechanisms.” Archives of General Psychiatry 58 (2001): 837-843.
Steinkruger, M. “Photosensitive epilepsy.” Journal of Neurosurgical Nursing 17.6 (1985): 355-361.
Steriade, M. “Slow-wave sleep: serotonin, neuronal plasticity, and seizures.” Archives Italiennes de Biologie 142.2 (July 2004): 359-367.
Stutsman, R. Merrill Palmer scale of mental tests. Chicago: Stoelting, 1948.
Szatmari, Peter. “The Epidemiology of Attention-Deficit Hyperactivity Disorder.” In Child and Adolescent Pcychiatric Clinics of North America, ed. W.B. Saunders and G. Weiss. Vol. 1. 1992.
Terron, J.A. “Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine?” European Journal of Pharmacology 439.1-3 (29 March 2002): 1-11.
Theodore, W.H. “Does Serotonin Play a Role in Epilepsy?” Epilepsy Current 3.5 (September 2003): 173-177.
Trottier, S., B. Evrard, J. P. Vignal, J. M. Scarabin, and P. Chauvel. “The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia.” Epilepsy Research 25.2 (October 1996): 79-106.
Van Esch, H., M. Syrrou, and L. Lagae. “Refractory photosensitive epilepsy associated with a complex rearrangement of chromosome 2.” Neuropediatrics 33.6 (December 2002): 320-323.
Van Heeringen, C. “Suicide, Serotonin and the Brain.” Crisis 22.2 (2001): 66-70.
Van Hooft, J. A., and H. P. Vijverberg. “5-HT(3) receptors and neurotransmitter release in the CNS: a nerve ending story?” Trends in Neuroscience 23.12 (2000): 605-610.
Villalon, C.M., D. Centurion, L.F. Valdivia, P. De Vries, and P.R. Saxena. “An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.” Proceedings of the Western Pharmacology Society 45 (2002): 199-210.
Welsh, J.P., B. Chang, M.E. Menaker, S.A. Aicher, and . “Removal of the inferior olive abolishes myoclonic seizures associated with a loss of olivary serotonin.” Neuroscience 82.3 (1998): 879-897.
---, D.G. Placantonakis, S.I. Warsetsky, R.G. Marquez, L. Bernstein, and S.A. Aicher. “Serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity.” Advances in Neurology 89 (2002): 307-329.
Will, B., and M. Rosenzweig. “Effects of differential environments on recovery from neonatal brain lesions, measured by problem solving scores.” Physiology and Behavior 16 (1976): 603-611.
Wood, B.L., S. Haque, A. Weinstock, B.D. Miller, and Division of Child and Adolescent Psychiatry, State University of New York at Buffalo, Buffalo, NY. “Pediatric stress-related seizures: conceptualization, evaluation, and treatment of nonepileptic seizures in children and adolescents.” Current Opinions in Pediatrics 16.5 (2004): 523-531.
Yan, X.X., J. Najbauer, C.C. Woo, K. Dashtipour, C.E. Ribak, and M. Leon. “Expression of active caspase-3 in mitotic and postmitotic forebrain cells of rat.” Journal of Comparative Neurology 433 (2001): 4-22
Order forms can be tiresome
and cumbersom if you have ordered of us before
A malfunctioning immune system
can cause allergies
immune system is important to cancer patients in many ways
Chemotherapy and radiotherapy can weaken immunity by causing a drop in the number of white blood cells made in the bone marrow. Apart from bone marrow or stem cell transplants, this effect on the bone marrow is temporary.
cells of the immune system can recognise cancer cells as abnormal
and kill them. Unfortunately, this is not enough to get rid of a
The individual has always
had to struggle to keep from being overwhelmed by the tribe.
The University of Southern California preformed clinical trials in 1934 with Rife machine technology on 16 terminally ill cancer patients and all 16 were cured within the trial period of 3 to 4 months. It is claimed that the treatment was painless, did not have side effects, did not harm healthy cells and did not include pharmaceutical treatment for the cancers
In the Fall of 1990, two researchers, Drs. William Lyman and Steven Kaali, working at Albert Einstein Medical College in New York City made an important discovery. They found that they could inactivate the HIV virus by applying a low voltage current to HIV infected blood in a test tube. They applied a direct current to the electrodes and found that a current flow in the range of 50-100 microamperes (uA) produced the most effective results. Practically all of the HIV viral particles were adversely affected while normal blood cells remained unharmed. The viral particles were not directly destroyed by the electric current, but rather the outer protein coating of the virus was affected in such a way as to prevent the virus from producing reverse transcriptase, a necessary enzyme needed by the virus to invade human cells.
Oxygen is not something that God reaches out from Heaven and replaces on this planet. Oxygen is primarily provided by photosynthesis from the trees and vegetation. The Amazon forests alone, just one hundred years ago, provided over one third of this planet’s global oxygen. Today, through deforestation and man’s greed, the Amazon basin is struggling to make three-sixteenths of our global oxygen. The ramifications of the former upon life on this planet are severe. Up and coming countries that are frantic to keep up with other commercially affluent countries, are expanding their commercial capabilities each day, consuming more and more energy
For those that have purchased our Rife/crane
Ces unit there are now new
Pre programed frequencies for your Desk top or
Rife machines and Multiwave oscillators are claimed to complement each other based on the principle that life forms absorb energy. A multiwave Oscillator uses this principle to strengthen cells within the body to resist disease while a Rife machine uses this principle to destroy microorganisms with an overdose of frequency energy.
illness ? medical professionals told you or a loved one
Waves That Heal
14-21 days delivery
Complimentary Alternative Health Site
Wonder What Happened!
DOES SILVER WORK AGAINST CANCER ?
The mutation of healthy cells
into cancer cells occur continuously, even in healthy bodies. But
such cancer cells are destroyed by the body's natural immune system
at a rate about the same as they occur, and when the body condition
is stable, there is nothing manifest that a healthy person would
experience as cancer. Some types of Cancer are reported to be caused
by a virus. Like with any virus, upon invading a body tissue cell
it will take over the cells reproductive chemical factory thereby
forcing the cell to replicate the virus instead, the cell will revert
to the primitive state thus enabling the Colloidal Silver to be effective
and kill the cancerous cell. A higher concentration of Colloidal
Silver means more immediate contact with any virus or other pathogen.
Disclaimer: To comply with FDA requirements we need to inform you the fact that a lot of people have had tremendous results does not guarantee that you will have the same results. Also, if you have a serious medical condition, this use of this technology should not replace any competent medical advice you are currently receiving. Our experiences have been that most people will use this technology while continuing to visit their usual/normal medical professionals
A SITE DEDICATED TO TRUTH, PEACE, JUSTICE, LOVE
FAIR USE NOTICE: This may contain copyrighted
(C ) material the use of which has not always been specifically authorized
by the copyright owner. Such material is made available for educational
purposes, to advance understanding of human rights, democracy, scientific,
moral, ethical, and